Boston Scientific Corporation vs Marathon Petroleum Corp — how do they compare? Boston Scientific Corporation trades at $51.05 (market cap $74.19B), while Marathon Petroleum Corp trades at $334.42 (market cap $94.48B). The key difference: Marathon Petroleum Corp is the larger of the two by market cap, and Marathon Petroleum Corp pays a 1.19% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | MPC | |
|---|---|---|
Market Cap | $74.19B | $94.48B |
Sector | Health | Energy |
52-Week High | $108.14 | $336.42 |
52-Week Low | $42.63 | $159.11 |
Enterprise Value | $86.27B | $121.00B |
Dividend Yield | — | 1.19% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →